Tianjin Zhongxin Pharmaceutical

Tianjin Zhongxin Pharmaceutical is one of the...

• CSI 500.

Tianjin Zhongxin Pharmaceutical is a company listed under the stock ticker 600329 (CN).

View the org chart displaying its 12 main executives

Most searched biographies at Tianjin Zhongxin Pharmaceutical

• Lei Wang, General Manager and Director
• Ping Zhang, Director
• Yubin Liu, Independent Director

Create your alert
to follow the executive moves at Tianjin Zhongxin Pharmaceutical.

Tianjin Zhongxin Pharmaceutical has 1,883 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).

Popular M&A news in Pharmaceuticals

• Generate Biomedicines has just announced a $273 Million fundraising (posted on September 19 2023).
• Harmony Biosciences has announced the acquisition of Zynerba Pharmaceuticals  (posted on August 15 2023).
• Biogen has announced the acquisition of Reata Pharmaceuticals  (posted on August 1 2023).

Popular contacts in Pharmaceuticals

• Kristin Peck - Chief Executive Officer and Director at Zoetis
• Danilo Cicmil - Supervisory Board Member at Galenika
• Lionel Viret - Chairman of the Board at Groupe Stago

Learn more about the Pharmaceuticals industry >

Press releases by Tianjin Zhongxin Pharmaceutical

Social media about Tianjin Zhongxin Pharmaceutical

• Tianjin Zhongxin Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Tianjin Zhongxin Pharmaceutical on LinkedIn, Twitter & YouTube

Call Tianjin Zhongxin Pharmaceutical at +86 222...

View the org chart

Register to receive your alert

Report an error